PredictCan Biotechnologies
![](https://i0.wp.com/3rc.org/wp-content/uploads/2024/04/Predictcan-Bio.jpg?fit=345%2C80&ssl=1)
“PredictCan Biotechnologies has patented cell education technology that exploits the intrinsic plasticity of cell lines by inducing subject-dependent phenotypic changes to better model cohorts of healthy or pathological individuals with tailored characteristics. The company generates state-of-the-art 3D individual-centric models for early detection of cancers, drug discovery, drug safety, and drug efficacy. Among our models, GenuineSelect-TOX is a platform that accurately detects intrinsic DILI and immune-mediated idiosyncratic DILI (iDILI) during the early and late stages of drug development.
STEMCELL Technologies
![](https://i0.wp.com/3rc.org/wp-content/uploads/2024/04/Stemcell-logo.jpg?fit=592%2C254&ssl=1)
We are the world-leading provider of reagents and services for generating organoid and stem cell-derived models of healthy and diseased human tissues.
AnaBios
![](https://i0.wp.com/3rc.org/wp-content/uploads/2024/03/ANABIOS-LOGO-F.jpg?fit=450%2C195&ssl=1)
AnaBios aims to establish the safety and efficacy of novel compounds through its advanced, human-focused translational technologies, including superior quality human tissue samples and functional assays focused, as well as human primary cells through its subsidiary Cell Systems.
Ncardia
![](https://i0.wp.com/3rc.org/wp-content/uploads/2023/07/Ncardia_Logo.jpg?fit=800%2C400&ssl=1)
For more than a decade, Ncardia has been pioneering innovations in human induced pluripotent stem cells (iPSC).
Ossiform
![](https://i0.wp.com/3rc.org/wp-content/uploads/2023/04/Logo@4xOSSIFORM.jpg?fit=800%2C212&ssl=1)
Ossiform provides scaffold-based bioceramic 3D cell culture systems that mimic the architecture and complexity of calcified bone tissue. The scaffolds are made from a nonpolymeric bioink consisting solely of β-TCP.
AlveoliX
![](https://i0.wp.com/3rc.org/wp-content/uploads/2021/06/AlveoliXS2.png?fit=800%2C336&ssl=1)
AlveoliX is a Swiss-based organ-on-chip company. Our product is comprised of different hardware components and the easy-to-handle organ-on-chip consumable AX12. On the AX12 healthy and diseased biomodels can be created to study drug safety and efficacy and to answer fundamental research questions.
InSphero
![](https://i0.wp.com/3rc.org/wp-content/uploads/2021/04/InSpheroS2.png?fit=800%2C336&ssl=1)
InSphero is the pioneer of industrial-grade, 3D-microtissue-based assay solutions and scaffold-free 3D organ-on-a-chip technology. The company specializes in liver toxicology, metabolic diseases (e.g., T1 & T2 diabetes and NAFLD & NASH liver disease), and immuno oncology.
Lena Biosciences
![](https://i0.wp.com/3rc.org/wp-content/uploads/2021/04/LenaS2.png?fit=800%2C336&ssl=1)
Lena Biosciences offers Perfused Organ Panel MPS with a Blood Substitute hemoglobin analog that yields a log-fold increase in CYP450 activity in primary human hepatocytes to identify mitotoxic metabolites and DILI. Services focus on efficacy and toxicity in liver, brain, tumor, and blood models.
Hesperos Inc.
![](https://i0.wp.com/3rc.org/wp-content/uploads/2021/04/HesperosS2-1.png?fit=800%2C336&ssl=1)
Hesperos is accelerating drug discovery by providing safety and efficacy testing services using its Human-on-a-Chip, microphysiological system. This breakthrough technology enables unprecedented preclinical insight bringing better therapies to patients faster without the need for animal testing.